Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Relay Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Cambridge, MA, United States

  1. PrincipalsDonald A BergstromPresident, R&DSanjiv PatelPresident and CEOThomas CatinazzoChief Financial Officerand 3 more
  2. CompanyRelay Therapeutics, Inc.Cambridge, MA, United States
  3. Phone line+1 (617) 370-8837General business
Request a quoterelaytx.com ↗

Relay Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker RLAY) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 6

Chief executive

Donald A BergstromPresident, R&D
Sanjiv PatelPresident and CEO

Chair & board

Habib J DableDirector (Board)
Lonnel CoatsDirector (Board)

Finance

Thomas CatinazzoChief Financial Officer
Everyone else on file (1)
Peter RahmerOfficer (see SEC filing)

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Donald A Bergstrom — President, R&D

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Thomas Catinazzo — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Peter Rahmer — Officer (see SEC filing)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers